Document is current
Any future updates will be listed below
-
Authors
Gericke, Germo
- License Information
-
More Information
Article History
Received: 30 April 2021
Accepted: 3 May 2021
First Online: 13 May 2021
Declarations
:
: Institutional Review Board approval was not required for this Letter to the Editor.
: Not applicable.
: Not applicable.
: The author is Chief Medical Officer of Advanced Accelerator Applications (AAA), a Novartis company.
